Today: 27 April 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Shell Plc stock price: Nigeria’s $20 billion Bonga push and buybacks set up Shell shares for a busy week

Shell Plc stock price: Nigeria’s $20 billion Bonga push and buybacks set up Shell shares for a busy week

Shell shares closed at 2,687.5 pence Friday, up 0.5%, after Nigeria approved incentives for its Bonga South West oil project. Shell repurchased 572,214 shares under its buyback plan, with Merrill Lynch managing the programme until Jan. 30. Oil prices rose sharply on new U.S. sanctions against Iran. Investors await Shell’s fourth-quarter results and dividend on Feb. 5.
25 January 2026
·
Anglo American share price ends near 1-year high as metal rally sets up the week ahead

Anglo American share price ends near 1-year high as metal rally sets up the week ahead

Anglo American shares closed up 1.08% at 3,378 pence in London on Friday, near their 52-week high. The stock rose about 4% over the week, boosted by metals prices and merger news following Anglo’s $53 billion deal with Teck Resources. Investors await Q4 production results on Feb. 5 and full-year earnings on Feb. 20. EU antitrust and subsidy rulings on the merger are due in early February.
25 January 2026
··
BAE Systems share price ends week higher — what to watch before London reopens

BAE Systems share price ends week higher — what to watch before London reopens

BAE Systems shares rose 2.1% to 2,027 pence Friday after the company reported new buyback activity and corrected a shareholder disclosure. The firm acquired 105,143 shares for cancellation and clarified Silchester Investors no longer holds a notifiable stake. BAE also secured a $73.8 million U.S. contract for aircraft countermeasures. Full-year results are due February 18.
25 January 2026
··
BP share price: buyback filing and a jump in oil set the tone for the week ahead

BP share price: buyback filing and a jump in oil set the tone for the week ahead

BP shares closed up 1.6% at 443.65 pence Friday after the company repurchased nearly 3 million shares for treasury. Brent crude settled at $65.88 a barrel, rising 2.8% on renewed supply concerns linked to Iran. A U.S. winter storm is cutting oil and gas output. BP recently flagged $4–5 billion in impairments tied to its energy transition businesses.
25 January 2026
···
iFAST share price jumps to S$10.37 — what to watch after SGX’s record close

iFAST share price jumps to S$10.37 — what to watch after SGX’s record close

iFAST Corp shares rose 3.39% to S$10.37 Friday, with 1.93 million shares traded, marking the stock’s highest close since end-2025. The Straits Times Index gained 1.3%, led by surges in UOB and OCBC. iFAST’s recent S$19.575 million deal for a 30% stake in Financial Alliance awaits regulatory approval. Singapore’s core inflation rose 1.2% year-on-year in December; MAS updates its forecasts Jan. 29.
25 January 2026
··
1 … 154 155 156 157 158 … 584

Stock Market Today

  • SQM Valuation Under Scrutiny Amid New Lithium Oversupply Concerns
    April 27, 2026, 5:29 PM EDT. Sociedad Química y Minera de Chile (SQM) faces fresh lithium market oversupply concerns raised by Rothschild & Co Redburn research. Despite recent share price gains-up 7.36% in 30 days and 27.33% year-to-date-SQM trades at $88.79 against a perceived fair value of $75.33, implying a 17.9% overvaluation. Expansion plans in Australia and Chile, including projects like Salar Futuro, bolster long-term growth potential, but lithium price volatility and Chilean regulatory risks cloud the outlook. Conflicting discounted cash flow (DCF) models add uncertainty, with one suggesting an intrinsic value of $113.84, highlighting divergent investor perspectives on SQM's earnings and growth prospects in a shifting lithium market.

Latest article

Oruka Therapeutics Stock Surges After Psoriasis Drug Data as Biotech Seeks $500 Million

Oruka Therapeutics Stock Surges After Psoriasis Drug Data as Biotech Seeks $500 Million

27 April 2026
Oruka Therapeutics reported its experimental psoriasis drug ORKA-001 achieved complete skin clearance in 63.5% of patients at 16 weeks. Shares jumped 10.5% to $76.39 before the company launched a $500 million public offering. No serious adverse events were reported in the trial. ORKA-001 is being developed as a long-acting injectable, with annual dosing possible.
Why Rambus Stock Fell Even as AI Memory Sales Jumped in Q1

Why Rambus Stock Fell Even as AI Memory Sales Jumped in Q1

27 April 2026
Rambus shares fell 10.8% to $141.31 Monday after reporting first-quarter revenue of $180.2 million and net income of $59.9 million. Product revenue rose 15% to $88 million, driven by AI data-center demand. The company forecast higher second-quarter product revenue but said results depend on customer deals. Rambus recently launched a new server memory module aimed at AI systems.
Go toTop